+145.2%
SPXL vs BBIO
+42.7%
+102.5%
-63.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.4% | -0.1% | +2.5% | +2.4% |
| 7D | -2.5% | -3.2% | +0.7% | -2.0% |
| 30D | -4.2% | -13.6% | +9.4% | -1.8% |
| 3M | +8.1% | +7.2% | +0.9% | +6.4% |
| 6M | +35.6% | +1.5% | +34.1% | +34.7% |
| YTD | +28.8% | -5.3% | +34.1% | +28.7% |
| 1Y | +39.8% | +37.7% | +2.1% | +30.4% |
| 3Y | +221.4% | +153.9% | +67.5% | +163.4% |
| All | +145.2% | +42.7% | +102.5% | +47.3% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling